The House Energy & Commerce Committee is expected to hold a hearing on FDA bills aimed at curbing the rise of drug prices, according to lobbyists for drug makers and patients, and the committee also might hold a hearing at the end of the month on pharmacy benefit managers. Despite having jurisdiction over Medicare Part D, Energy & Commerce is one of the last committees to initiate hearings on drug prices. There have been several drug price hearings, with two...